EXOR Balanced Scorecard

EXOR Balanced Scorecard

Fully Editable

Tailor To Your Needs In Excel Or Sheets

Professional Design

Trusted, Industry-Standard Templates

Pre-Built

For Quick And Efficient Use

No Expertise Is Needed

Easy To Follow

EXOR Bundle

Get Full Bundle:
$15 $10
$15 $10
$15 $10
$15 $10
$15 $10
Icon

Make Smarter Expansion Decisions with the Full Report

This EXOR Balanced Scorecard Analysis gives you a structured view of the company's financial, customer, internal process, and learning-and-growth priorities. The page already shows a real preview of the actual analysis, so you can review the content before buying. Purchase the full version to get the complete ready-to-use report.

Benefits

Icon

Capital Discipline

Capital discipline links Exor's capital calls to hard outcomes like NAV growth and return on capital. In 2025, that mattered because Exor's NAV was about €38 billion, so even a 1% swing means nearly €380 million of value. For a holding company, that makes add, hold, and recycle choices easier to judge.

Icon

Portfolio Alignment

A scorecard gives Exor one management language across its 4 core areas: automotive, luxury, healthcare, and financial services. It helps compare very different assets on the same terms, without pretending a car maker, a brand house, and a lender are the same.

That matters in FY2025, when Exor still had to balance a portfolio built around Stellantis, Ferrari, Philips, and Ferrari-like high-value holdings under one capital lens. The result is clearer capital moves, faster trade-offs, and tighter portfolio alignment.

Explore a Preview
Icon

Active Ownership

Active ownership works best when the scorecard tracks board engagement, milestone delivery, and value actions across EXOR's 5 core holdings. It makes influence visible in outcomes, not just in press releases. In 2025, that matters across assets like Ferrari, Stellantis, CNH, Philips, and Iveco, where governance and execution drive returns.

Icon

Long Horizon

A long horizon fits EXOR because value here builds over years, not quarters. A Balanced Scorecard adds leading indicators, so EXOR can track innovation, execution, and governance before they show up in reported earnings. That matters when capital is tied to long bets like Stellantis, Ferrari, and Iveco Group, where strategy shifts can take multiple fiscal years to pay off. It also helps EXOR spot risk early and keep capital allocation disciplined.

Icon

Risk Radar

Risk Radar shows concentration, leverage, liquidity, and sector exposure across EXOR's portfolio, so one weak link can be caught before it hurts the whole book. That matters in 2025, when EXOR still leaned on a small set of listed anchors like Ferrari, Stellantis, and CNH, making early warnings more useful than after-the-fact reviews.

It gives the board a fast check on where value, cash, and funding risk sit. In a diversified holding company, that can protect capital and keep the balance between growth bets and downside control.

Icon

EXOR FY2025: €38B NAV, €380M per 1% move

In FY2025, EXOR's Balanced Scorecard sharpened capital discipline around a €38 billion NAV, so a 1% move equals about €380 million. It also gave one way to compare Stellantis, Ferrari, CNH, Philips, and Iveco on value, execution, and risk.

Benefit FY2025 data
NAV focus €38 billion
Value swing ~€380 million per 1%
Core holdings 5

What is included in the product

Word Icon Detailed Word Document
Analyzes EXOR's strategic performance across financial, customer, process, and learning perspectives
Plus Icon
Excel Icon Editable Excel File
Provides a quick Balanced Scorecard view of EXOR's financial, customer, process, and growth priorities for faster decision-making.

Drawbacks

Icon

KPI Mismatch

KPI mismatch is a real drawback for EXOR. Ferrari's luxury model, Stellantis's volume-driven auto cycle, and Philips's healthcare business all need different scorecards, so one set of KPIs can hide where value is really created. For example, Ferrari's 2025 focus is pricing power and margins, while Stellantis and Philips depend more on unit mix, cash flow, and execution discipline.

Icon

Reporting Lag

Reporting lag is a real weakness in EXOR's scorecard because quoted holdings like Ferrari, Stellantis, CNH Industrial, and Philips report on fixed market calendars, while private assets disclose less and later. That can leave EXOR comparing 2025 data from different dates, so the portfolio view can be stale by one to three quarters. When that happens, reaction time drops and capital moves may be based on old signals.

Explore a Preview
Icon

Weighting Risk

Weighting risk is the weak spot in any balanced scorecard: if non-financial measures are set too high or too low, EXOR can end up optimizing the dashboard, not the business. In 2025, that matters even more because EXOR still had to balance capital across a multi-sector portfolio, so a bad weight mix can steer attention away from cash flow, return on invested capital, and long-term value. Keep the weights tied to 2025 results and review them often, or the scorecard can reward activity over outcomes.

Icon

Partial Control

Exor's 2025 exposure is large but not total: it held about 24.9% of Ferrari and 15.9% of Stellantis, so it can steer strategy but not run every lever. That matters in a scorecard, because a red flag at one holding does not mean Exor can force fixes on its own. The model can spot weak margins or capital use, but execution still depends on boards and co-owners.

Icon

Admin Load

Admin load is a real weakness for EXOR if its Balanced Scorecard needs heavy upkeep, because tracking too many metrics eats management time and data work. The more detailed the system gets, the more it can slow investment calls and pull attention away from capital allocation, which is the core job at a holding company. For EXOR, that matters because even one extra review layer can delay decisions across a portfolio of major assets and reduce speed in shifting cash to the best return.

Icon

EXOR's KPI Mismatch Can Blur True Value Signals

EXOR's main drawback is KPI mismatch: Ferrari, Stellantis, and Philips need different 2025 scorecards, so one dashboard can blur margin, unit, and cash flow signals. Reporting lag is another issue, because listed holdings update on set calendars while private assets report later, so the portfolio view can be stale by one to three quarters. Weighting also matters: if non-financial metrics are overweighted, the scorecard can distract from return on invested capital and cash flow.

Drawback 2025 data point
Ownership limit Ferrari 24.9%, Stellantis 15.9%
Data lag 1 to 3 quarters
Scorecard risk KPI mix can miss value drivers

What You See Is What You Get
EXOR Reference Sources

This is the actual EXOR Balanced Scorecard analysis document you'll receive upon purchase – no mockup, no filler, just the real report. The preview below is taken directly from the full file, so what you see is what you get. Once purchased, you'll unlock the complete, detailed version ready to use.

Explore a Preview

Frequently Asked Questions

It measures how well Exor turns capital into durable portfolio value over time. The most useful signals are NAV growth, portfolio ROIC, and the discount or premium to NAV. For a holding company with assets in 4 sectors, those 3 indicators show whether active ownership is compounding value rather than just producing accounting earnings.

Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site - including articles or product references - constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.